LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2017

Mar 1, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2017-02-28

Reporting Person: COATS LONNEL (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-02-28	Common Stock	M	10836	—	Acquired	17635	Direct
2017-02-28	Common Stock	M	8390	—	Acquired	26025	Direct
2017-02-28	Common Stock	F	5258	$16.45	Disposed	20767	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-02-28	Restricted Stock Units (Phantom Stock)	$	M	10836	Disposed		Common Stock (10836)	Direct
2017-02-28	Restricted Stock Units (Phantom Stock)	$	M	8390	Disposed		Common Stock (8390)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of common stock.

F2: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.

F3: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2016 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.

F4: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.